Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 223Pancreatic Neoplasms 140Stomach Neoplasms 87Carcinoma, Hepatocellular 82Carcinoma, Non-Small-Cell Lung 64Esophageal Neoplasms 63Colonic Neoplasms 60Breast Neoplasms 52Rectal Neoplasms 50Ovarian Neoplasms 46Neoplasm Metastasis 41Lung Neoplasms 41Cholangiocarcinoma 41Neoplasms 39Prostatic Neoplasms 33Melanoma 33Liver Neoplasms 33Gastrointestinal Neoplasms 33Sarcoma 27Endometrial Neoplasms 27Carcinoma, Renal Cell 24Squamous Cell Carcinoma of Head and Neck 23Biliary Tract Neoplasms 23Urinary Bladder Neoplasms 21Uterine Cervical Neoplasms 19Esophageal Squamous Cell Carcinoma 19Head and Neck Neoplasms 16Adenocarcinoma Of Esophagus 16Small Cell Lung Carcinoma 15Gastrointestinal Stromal Tumors 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuralgia × Gastrointestinal × 30 days × Clear all
NCT06848348 2026-05-29

Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

Dogwood Therapeutics Inc.

Phase 2 Recruiting
240 enrolled
BreastGastrointestinal

Cancer Pain, Breast Neoplasms, Neoplasms, Neuralgia, Pain, Peripheral Nervous System Diseases, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡